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The RNase III enzyme Dicer is responsible for key
steps in the biogenesis of small RNA species in
multiple RNA interference pathways. Here, we show
that, in the adult C. elegans soma, half of the total
DCR-1 protein is expressed as a truncated, stable
C-terminal fragment named small DCR-1 (sDCR-1).
sDCR-1 operates independently of full-length
DCR-1 in two distinct RNAi pathways; it enhances
exogenous RNAi (exoRNAi) and concurrently acts
as a negative regulator of microRNA (miRNA) biogen-
esis. Enhancement of exoRNAi relies on sDCR-1
catalytic activity, whereas impinging on miRNA pro-
cessing does not. Instead, sDCR-1 competes with
pre-miRNA processing by interacting with the
miRNA-dedicated Argonautes ALG-1 and ALG-2.
Finally, triggering a strong exoRNAi response in the
presence of elevated levels of sDCR-1 exacerbates
the miRNA processing defect. Our results unveil a
surprising role for a truncated form of DCR-1 in the
modulation ofmultipleRNAi activities and in the regu-
lation of mechanistic boundaries between pathways.INTRODUCTION
As master regulatory processes, RNA interference (RNAi) phe-
nomena orchestrate complex and evolutionary conserved pro-
grams of gene silencing. At the crux of these events is the highly
conserved RNase III enzyme Dicer (DCR-1 in C. elegans). Dicer
is essential for the biogenesis of the small RNA species, which
direct the sequence specificity of silencing (Bernstein et al.,
2001) as part of the microRNA (miRNA), exogenous (exo)RNAi
and ERI endogenous (endo)RNAi pathways. miRNA hairpin pre-
cursors are processed via the sequential actions of Drosha and
Dicer, along with their cofactors. miRNAs then associate with
the Argonaute proteins into an effector complex termed RNA-
induced silencing complex (RISC) and pair via complementary
sequences to their target messenger RNAs to instigate silencing
posttranscriptionally (Ambros, 2004; Bartel, 2009). exoRNAi is
characterized by targeted silencing through the action of exoge-454 Cell Reports 4, 454–463, August 15, 2013 ª2013 The Authorsnous long double-stranded RNA (dsRNA), which is processed
into small interfering RNAs (siRNAs) and incorporated into the
RISC to direct negative transcriptional and posttranscriptional
target regulation (Fire et al., 1998; Hannon, 2002; Mello and
Conte, 2004; Song et al., 2004). The ERI endoRNAi pathway in-
volves a separate class of small interfering RNAs (26G siRNAs)
and a specialized DCR-1 multiprotein complex required for their
production (Duchaine et al., 2006; Lee et al., 2006; Pavelec
et al., 2009). In addition to trigger dsRNA cleavage, Dicer
facilitates the loading of small RNAs onto the RISC and is
a stable component of the holo-RISC in many species (Kim
et al., 2007; Lee et al., 2004; Maniataki and Mourelatos, 2005;
Pham et al., 2004). Although several organisms have evolved
distinct Dicer-like genes exclusive to specific pathways, both
humans and C. elegans genomes encode one Dicer gene; there-
fore, it stands to reason that its activities are differentially regu-
lated in each RNAi pathway.
DCR-1 is a large, multidomain enzyme that contains an
N-terminal DExD/H box family helicase domain and substrate
recognition domain (PAZ), a domain of unknown function
(DUF), as well as C-terminal catalytic RNase III (RIII) domains
and a dsRNA-binding domain (dsRBD). The dual RNase III
domains of DCR-1 dimerize to form the catalytic core of the
enzyme, with each domain responsible for the cleavage of one
strand of the dsRNA substrate (Macrae et al., 2006; Takeshita
et al., 2007; Zhang et al., 2004). The N-terminal domains are
joined to the catalytic core by a flexible linker region of the pro-
tein, which is proposed to act as a molecular ruler to determine
the size of the small RNAs generated (Macrae et al., 2006;
Park et al., 2011).
Here, we report that the proteolytic processing of DCR-1
generates a truncated C-terminal form, which influences the
regulation of RNA interference mechanisms.RESULTS
Small DCR-1: An Abundant, Developmentally Regulated
C-Terminal Fragment of DCR-1
In the course of analyzing full-length (FL) endogenous DCR-1
expression, we noticed that a polyclonal antibody directed
against the C-terminal linker (Figure 1A) also detected an abun-
dant and previously unidentified band migrating at 95 kDa.
Both bands were lost in DCR-1-depleted animals (DCR-1
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Figure 1. Endogenous DCR-1 Is Expressed as Full-Length and Small DCR-1
(A) Schematic representation of full-length DCR-1 with the anti-DCR-1 polyclonal antibody epitope indicated.
(B) Western blot of WT extracts compared to DCR-1-depleted extracts. Nonspecific proteins detected by the polyclonal antibody are indicated with *.
(C) Western blots of total lysate and IPs of WT endogenous DCR-1 alone (lanes with []) or with additional C-terminally tagged DCR-1-8HA (lanes with [+]).
(D) Western blot of DCR-1 and sDCR-1 over 3 hr postextract preparation. The stability of sDCR-1 (normalized to FL DCR-1 with the initial levels set to 1) is
quantified (lower panel); n = 3 biological replicates.
(E) Western blot of endogenous DCR-1 in stage-synchronizedWT animals in early embryos (EE), midstage embryos (ME), late embryos (LE), and the larval stages
L1–L4. The nonspecific band in L1, indicated by **, was confirmed to be not sDCR-1 (Figure S1). FL DCR-1 consistently migrates as a doublet, indicating possible
posttranslational modification.
(F) Quantification of sDCR-1 done by western blot using the intensity of sDCR-1 relative to total DCR-1 (sDCR-1 + FL DCR-1) in S100 extracts; n = 3 biological
replicates. Data represented as mean ± SD. A representative blot is shown (right), and no significant difference in the ratio was found between S10 and S100
extracts.
(G) Western blot of adult extracts fromWT animals (late gravid) compared to two temperature-sensitive germline-deficient alleles of glp-4 and fem-1 grown at the
nonpermissive temperature.
See also Figure S1.
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Figure 2. sDCR-1 Is Generated In Vivo via
Proteolytic Cleavage between the PAZ and
RNase IIIa Domains
(A) Schematic representation of endogenous
(➀and➃) and transgenicDCR-1proteins (➁and➂).
(B and C) Western blots of total lysates and IPs
from WT animals or a transgenic line carrying the
myo-3-driven MYC-pre-sDCR-1-3FLAG.
(D) Deletions within the pre-sDCR-1 transgene
were generated with an HA tag insertion at the
indicated regions. Western blots on FLAG IPs of
mixed stage animals using the anti-DCR-1 or
antibodies against HA to monitor the generation of
sDCR-1 and the orientation of potential proteolytic
cleavage. The arrow indicates the major band of
the sDCR-1 doublet, indicating modification or
major and minor cleavage sites.
(E) Western blot of animals expressing full-length
DCR-1 constructs from either genomic DNA
(C-terminal 3FLAG) or cDNA (C-terminal 2FLAG).
Samples were run on the same gel, and different
exposures are shown to normalize for expression
level. Negative controls are WT (N2) and sur-
5::GFP (coinjection marker) alone. Nonspecific
bands marked with *.
See also Figure S2.m+/z) (Figure 1B). A strain expressing an 8HA-tagged FL
DCR-1 also expressed the shorter polypeptide, with a shift in
size corresponding to the epitope tag (Figure 1C). Furthermore,
both FL DCR-1 and the shorter species remained stable in
extracts incubated on ice or at room temperature and even in
the absence of protease inhibitors, arguing against its produc-
tion during extract preparation (Figures 1D and S1). Thus,
C. elegans DCR-1 is also expressed as a truncated, stable,
C-terminal fragment. We named this polypeptide small- or
sDCR-1. sDCR-1 expression markedly increased in later larval
stages (Figure 1E) and reached approximately a 1:1 ratio with
FL DCR-1 in the adult (Figure 1F). Finally, comparison with adults
lacking germline tissue or sperm cells indicated an enrichment of
sDCR-1 over FL DCR-1 in the somatic tissues (Figure 1G).456 Cell Reports 4, 454–463, August 15, 2013 ª2013 The AuthorsBased on the migration of sDCR-1 on
SDS PAGE and antibody mapping (Fig-
ure 1C), we estimated that sDCR-1 is
composed of an intact C terminus con-
taining both RNase III domains and the
dsRBD and may lack the N-terminal heli-
case, DUF, and PAZ domains. To map
what is encoded within the sDCR-1 poly-
peptide, we constructed a transgene en-
compassing residues 957–1910, which
includes the linker region, the RNase
IIIa and b, and the dsRBD. The trans-
genic protein was tagged with N-termi-
nal MYC and C-terminal 3FLAG epitope
tags (Figure 2A). Since sDCR-1 is en-
riched in somatic tissues (Figure 1G),
we elected to drive the transgene from
the muscle-specific myo-3 promoter(Fire and Waterston, 1989), and independent lines were gener-
ated. In extracts of the strain expressing MYC-pre-sDCR-1-
3FLAG, western blotting with an antibody against MYC
revealed that the transgene-derived protein migrated at
135 kDa (Figure 2B). Immunoprecipitations (IPs) with anti-
MYC and western with the DCR-1 antibody detected only
one polypeptide, corresponding to the entire transgene-driven
fusion (Figure 2B). However, IPs with anti-FLAG detected two
proteins originating from the MYC-pre-sDCR-1-3FLAG trans-
gene (Figure 2C). The smaller polypeptide detected is consis-
tent with the size of sDCR-1 with the intact 3FLAG C-terminal
tag (Figure 2C). Similar results were obtained from let-858
promoter-driven transgenes (below; see also Figure S3B).
Hence, both the endogenous DCR-1 and the transgenic
MYC-pre-sDCR-1-3FLAG produce a C-terminal truncated pro-
tein in vivo.
sDCR-1 Is Generated through Proteolytic Cleavage
Expression of FL DCR-1 from either genomic DNA or comple-
mentary DNA (cDNA) in transgenic animals produced indistin-
guishable proteins for both FL DCR-1 and sDCR-1 (Figure 2E),
ruling out expression of sDCR-1 by alternative splicing and sug-
gesting a proteolytic biogenesis. In order to map the N terminus
of sDCR-1, we took advantage of the fact that MYC-pre-sDCR-
1-3FLAG produces sDCR-1-3FLAG in vivo (Figure 2C). From
large-scale FLAG purifications, the band corresponding to
sDCR-1-3FLAGwas submitted tomass spectrometry. We found
a drop-off in the peptide coverage near position 1200 in the pro-
tein sequence of DCR-1 (Figure S2) and subsequently designed
deletions on the MYC-pre-sDCR-1-3FLAG transgene in order to
abolish a putative cleavage event. Deletions were designed to
encode an internal hemagglutinin (HA) tag to orient the fragments
of DCR-1 produced relative to putative cleavage site(s) (see
Extended Experimental Procedures; Tables S1 and S2). Deletion
of amino acids 1163–1184 (deletion 2) most severely altered the
generation of sDCR-1 and abolished themajor band detected by
western blot (Figure 2D), indicating that these residues are inte-
gral to proteolytic cleavage. Deletion of amino acids 1200–1221
(deletion 3) diminished but did not abolish sDCR-1 and is located
C-terminal to cleavage (Figure 2D, HA blot). Deletion of the inter-
vening sequence between deletion 2 and 3 had no effect on
sDCR-1 production (data not shown). These results indicate
that the determinants of cleavage may span an extended or
complex sequence.
sDCR-1 Enhances exoRNAi and Impinges on miRNA
Biogenesis
We next tested the effect of sDCR-1 on the exoRNAi pathway by
performing unc-22 RNAi on wild-type (WT) and animals bearing
enforced sDCR-1 expression (sDCR-1+). The unc-22 phenotype,
ranging from varying degrees of body wall muscle twitching to
complete paralysis, can be used as a quantitative readout of the
potency of exoRNAi (Fire et al., 1998; Yigit et al., 2006). Three in-
dependent lines of muscle-restricted MYC-pre-sDCR-1-3FLAG
(pmyo-3::sDCR-1+) displayed a 5- to 14-fold enhancement of
paralysis in progeny (F1) (Figure 3A, left), which demonstrates
that sDCR-1 enhances the exoRNAi pathway. Furthermore, a
ubiquitous let-858-driven sDCR-1+ (two lines displaying mild 4X
and 8X expression of sDCR-1 over the endogenous FL DCR-1;
see Figure S3B) resulted in an 18- to 31-fold enhancement of
the exoRNAi response over WT levels (Figure 3A, right). Impor-
tantly, when the conserved catalytic residues in the RNase III
domains were inactivated in theMYC-pre-sDCR-1-1FLAG trans-
gene, the resulting protein did not enhance exoRNAi (Figure 3A,
left; myo-3::catsDCR-1+), despite comparable expression levels
(Figure S3B). Thus, the catalytic activity of sDCR-1 is required for
the enhancement of the exoRNAi response.
We also tested the effect of an early enforcement of sDCR-1
expression on a battery of conserved and developmentally
important miRNAs (Figure 3B). In embryos, sDCR-1 caused a
substantial (4- to 8-fold) accumulation of the precursor (pre-)
miR-58 (bantam) and pre-miR-35, as well as a decrease in thelevel of maturemiR-35 (22%–41%), which is an abundantmiRNA
key to embryonic development (Alvarez-Saavedra and Horvitz,
2010). In L2 to L3 stage animals, sDCR-1 caused an accumula-
tion of pre-lin-4 (2.4- to 3.2-fold), a key regulator of develop-
mental timing and fate of neuronal and hypodermal cell lineages
(Feinbaum and Ambros, 1999; Lee et al., 1993; Moss et al., 1997;
Olsen and Ambros, 1999). In contrast, sDCR-1+ caused a reduc-
tion in the levels of both pre-let-7 (24%–59%) and mature let-7
(36%–52%), a miRNA required for the transition between L4
and adult cell fates (Reinhart et al., 2000; Slack et al., 2000)
and a member of a larger miRNA family that also controls earlier
developmental decisions (Abbott et al., 2005; Esquela-Kerscher
et al., 2005). Thus, heightened levels of sDCR-1 earlier in devel-
opment result in broad defects in pre- and mature miRNA
expression with varying severity, the most robust of which being
the accumulation of pre-miRNAs.
To examine the interplay between the miRNA and exoRNAi
functions of sDCR-1, we took advantage of the pmyo-
3::sDCR-1 transgene, the expression of which overlaps with
the muscle-specific unc-22 gene and mir-1. miR-1 is a key
miRNA for muscle differentiation and integrity (Lee and Ambros,
2001; Mansfield et al., 2004; Sokol and Ambros, 2005; Wien-
holds and Plasterk, 2005; Zhao et al., 2005). Pre-miR-1, while
low in abundance in WT animals, accumulated in the sDCR-1+
strain without a detectable change in mature miRNA (Figure 3C),
similar to the changes seen in lin-4. The ratio of miR-1 to pre-
miR-1 in sDCR-1+ animals was reduced approximately 10-fold
(Figure 3D). In addition, pre-miR-1 accumulation was still visible
in animals expressing catalytically inactive sDCR-1, although to
a lesser level (Figure 3C). Thus, in contrast with its role in
enhancement of exoRNAi, the catalytic activity of sDCR-1 is
not required for the accumulation of pre-miRNAs. Surprisingly,
inhibition of pre-miR-1 processing was exacerbated when trig-
gering exoRNAi. In pmyo-3::sDCR-1+ or catsDCR-1+ animals,
triggering unc-22 RNAi significantly reduced the ratio of mature
to pre-miR-1 (Figures 3C and 3D, right). These results indicate
that high levels of sDCR-1 allow exoRNAi to compete with pre-
miRNA processing and suggest that expression of sDCR-1 alters
the mechanistic boundaries between the exoRNAi and miRNA
pathways.
We next tested whether the molecular defects induced by the
early expression of sDCR-1 could alter the physiology of the an-
imal. To compare WT to plet-858::sDCR-1+ animals, synchro-
nized P0 L4 animals were isolated and their progeny (F1) were
scored for developmental progression and brood size. Strikingly,
sDCR-1+ animals displayed delayed developmental progression
(Figure 3E), and animals reaching maturity had significantly
reduced brood size (Figure 3F). To further test the physiological
implications of early sDCR-1+ expression and since we
observed a marked reduction in mature let-7 expression (Fig-
ure 3B), we asked whether sDCR-1+ could genetically interact
with the temperature-sensitive allele let-7(n2853). This mutant
displays temperature-sensitive adult lethality due to bursting
vulva, a phenotype visible at 20% penetrance at permissive
16C (Reinhart et al., 2000; Slack et al., 2000). Transgenic let-
7(n2853); plet-858::sDCR-1+ F1 animals displayed several
phenotypes, including 47%embryonic or L1 arrest, 14% lethality
before L4, and 2% sterility. Of those animals that survived toCell Reports 4, 454–463, August 15, 2013 ª2013 The Authors 457
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Figure 3. sDCR-1 Enhances exoRNAi and Represses miRNA Biogenesis via Distinct Mechanisms
(A) Complete paralysis of the animals exposed to unc-22RNAi was quantified (nR 3 biological replicates of P0 animals) inWT adults compared to strains carrying
an additional myo-3, let-858-driven pre-sDCR-1, or a catalytically inactive version of pre-sDCR-1 (catsDCR-1).
(B) Northern blots of miR-35, miR-58, lin-4, and let-7 on RNA from animals at the indicated stages.
(legend continued on next page)
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adulthood, 53% displayed bursting vulvas (Figure 3G), a let-7
signature phenotype that was exacerbated compared to a con-
trol GFP transgene alone (Figure S3C). plet-858::sDCR-1+ trans-
genesis in let-7(n2853) failed to produce stable transmitting
lines, whereas GFP injection produced several, suggesting that
sDCR-1 expression may also have a negative effect on the
fertility or viability of the F1 mosaic-expressing animals. These
data show that early enforcement of sDCR-1 expression exacer-
bates let-7 phenotypes and leads to severe pleiotropic develop-
mental defects.
sDCR-1 Selectively Interacts with the miRNA
Argonautes ALG-1 and ALG-2
Given the abundance of sDCR-1 relative to FL DCR-1 and since
this function does not require catalytic activity, we reasoned that
it may act as a competitor by sequestering interacting RNAi
cofactors. To test this idea, IPs of endogenous DCR-1, trans-
genic MYC-pre-sDCR-1-3FLAG, and sDCR-1-3FLAG were
probed for components of three known DCR-1-dependent
RNAi pathways (Figure 4A). While they co-IP with FL DCR-1,
the ERI complex (ERIC) components ERI-1b and ERI-5 did not
interact with sDCR-1-3FLAG. Such results concur with the map-
ping of the ERI proteins to the N terminus of FL DCR-1 (Thivierge
et al., 2012). Furthermore, sDCR-1 did not interact with the
dsRNA-binding protein RDE-4, an essential cofactor of DCR-1
in exoRNAi (Tabara et al., 2002). This finding demonstrates
that RDE-4 interacts with the N terminus of FL DCR-1 and indi-
cates that sDCR-1 can initiate and/or enhance exoRNAi without
a stable physical interaction with RDE-4. In contrast, sDCR-1 did
co-IP the miRNA-specific Argonautes ALG-1 and ALG-2
(Grishok et al., 2001; Figure 4A). In a reciprocal experiment,
ALG-2 coimmunoprecipitated endogenous FL DCR-1 as well
as sDCR-1 (Figure 4B). To determine whether sDCR-1 contacts
miRNA species in vivo, we probed the IPs by northern blot.
Neither mature nor pre-miRNAs could be detected in sDCR-1
IP (Figure 4C). In contrast, IP of ALG-2 under the same condi-
tions enriched mature and pre-let-7 (Figure 4D). Finally, affinity
pull-down of mature miRNA-induced silencing complex
(miRISC) failed to capture FL or sDCR-1, while effectively
capturing ALG-1 and ALG-2 (Figure S4). Thus, sDCR-1 does
not stably associate with mature or pre-miRNAs. These results
support a model wherein sDCR-1 sequesters the Argonautes
from the functional FL DCR-1 complex or the mature miRISC,
thus acting as a competitive inhibitor in miRNA processing (Fig-
ures 4E and 5, model).
DISCUSSION
sDCR-1 reaches an exceptionally high level relative to FL DCR-1,
nearing 1:1 in the somatic tissue of adults. This prompts the pos-(C) Northern blot of the muscle-specific miR-1 in RNA of WT adults compared to p
WT animals was enriched for small RNAs to reach detectable levels of pre-miR-
(D) Quantification of the ratio of mature miR-1 to precursor miR-1, with or witho
precursor miRNA for each lane. nR 3 biological replicates.
(E) Developmental staging of WT or plet-858::sDCR-1+ F1 animals after P0 L4 a
(F) Brood sizes of WT and plet-858::sDCR-1+ animals. Data represented as mea
(G) Phenotype of F1 transgenic let-7ts (n2853) animals after microinjection of ple
See also Figure S3.sibility of competition between sDCR-1 and FL DCR-1 for inter-
acting cofactors and substrates. Our data indicate that sDCR-1
indeed interacts with the ALG-1 and ALG-2 Argonautes but not
with pre-miRNAs or mature miRNAs. In several systems,
including C. elegans, Argonautes are required not only for
miRISC function but also for pre-miRNA processing (Grishok
et al., 2001). Furthermore, Argonaute abundance is often limiting
for RNAi mechanisms (Diederichs et al., 2008; Lund et al., 2011;
Yigit et al., 2006). Consistently, enforced early expression of
sDCR-1 mimics the pre-miRNA accumulation observed in
ALG-1/ALG-2 or DCR-1 depletion (Grishok et al., 2001).
Together with the fact that catalytically inactive sDCR-1 causes
similar defects, our observations are consistent with a model
wherein sDCR-1 functions by sequestering the Argonaute pro-
teins, preventing pre-miRNA recognition and loading of mature
miRNAs. Curiously, the severity of the defect observed in
sDCR-1+ transgenics is miRNA-specific. This may be due to
differences in pre-miRNA structure, affinity for the complexes,
onset of expression, stability, and the incidence of alternate
routes of control by degradation.
DCR-1 cleavage occurs in a poorly conserved region between
the PAZ and RNase III domains and therefore excludes the
N-terminal DExD/H RNA helicase, DUF283, and PAZ domains.
Interaction analyses further indicate severance from RDE-4
and ERIC protein interactions. Possible mechanistic implications
for sDCR-1 functions can be suggested based on thewell-estab-
lished properties of the excluded domains. Enhancement of
exoRNAi could, at least in part, be explained by the loss of the
helicase domain, which inhibits the catalytic efficiency of human
Dicer (Ma et al., 2008). The helicase also directs a processive
mode of dsRNA cleavage in FL DCR-1 (Cenik et al., 2011;Welker
et al., 2011); thus, it could be predicted that sDCR-1 functions as
a single-turnover enzyme. Furthermore, since sDCR-1 lacks a
PAZ domain, it lacks the ‘‘molecular ruler’’ responsible to pre-
cisely determine the size of the small RNA products (Macrae
et al., 2006; Park et al., 2011). In line with this, a recent report
shows that a recombinant human Dicer C-terminal fragment en-
coding the same domains as sDCR-1 generates a slightly
broader size range of products that is still consistent with siRNA
lengths (20–23 nt; Ma et al., 2012).
Using mildly enforced and early sDCR-1 expression, we were
able to assess the physiological significance of the timing and
extent of sDCR-1 production. We reason that the regulated
expression of sDCR-1 and its system-oriented role in permitting
competition between pathways reflect different physiological
requirements for RNAi pathways at distinct developmental
stages. A low level of sDCR-1 in the embryo is necessary to
permit important functions of miRNAs in early developmental
decisions and to avoid severe pleiotropic phenotypes. Nearing
completion of development, higher levels of sDCR-1 canmyo-3::sDCR-1+ or catsDCR-1+ lines, with or without unc-22 RNAi. RNA from
1 (WT-enriched lane).
ut unc-22 RNAi triggered. Loading is normalized internally as mature miRNA/
nimals are isolated and propagated at room temperature for 4 days.
n ± SD. nR 3 biological replicates.
t-858::sDCR-1.
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Figure 4. sDCR-1 Specifically Interacts with the miRNA Argonautes ALG-1 and ALG-2
(A) IPs of total DCR-1 proteins (DCR-1) compared to sDCR-1 specifically (MYC and FLAG) in WT and pmyo-3::sDCR-1+ animals probed for known FL DCR-1
cofactors.
(B) IPs of ALG-2 in WT (negative control) and a strain carrying a rescuing ALG-2::GFP transgene probed for DCR-1.
(C and D) RNA extracted from (C) sDCR-1 or (D) ALG-2 IPs and probed for let-7.
(E) Schematic representation of FL DCR-1 and sDCR-1 interacting proteins.
See also Figure S4.provide heightened exoRNAi defense against RNA-based path-
ogens. High levels of sDCR-1 may then serve to permeate the
functional insulation between miRNA and exoRNAi pathways,
thus tilting the balance of the RNAi mechanisms. Determining
the full biological implications of sDCR-1 regulatory functions
will require complete prevention of its production. Thus far, FL
DCR-1 constructs bearing the large deletions required to impair
sDCR-1 processing (Figure 2) failed to rescue dcr-1 animals
(data not shown). We reason that the linker region is important
for generating miRNA products with fidelity, and it is likely that
such broad deletions result in fatal defects in FL DCR-1 func-460 Cell Reports 4, 454–463, August 15, 2013 ª2013 The Authorstions and obscure the phenotypes resulting from the loss of
sDCR-1.
Interestingly, recent reports on alternative splicing of human
DICER revealed isoform ‘‘e’’, which encodes a protein sharing
the same domains as sDCR-1 and is expressed in differentiated
epithelial cells as well as a number of breast cancer cell lines
(Grelier et al., 2009; Hinkal et al., 2011). When we ectopically
expressed isoform e in HEK293T cells, we observed a mild,
but significant reduction in the ratio of mature to precursor for
let-7 (Figure S3) but not miR-19b, indicating that, similar to
sDCR-1, this function is miRNA-specific. Possible conservation
competitive inhibition
sDCR-1
 FL DCR-1
proteolytic cleavage
loss of: Helicase, DUF, PAZ 
?
enhanced exoRNAi inhibited miRNA biogenesis
... ...
sDCR-1
ALG 1/2
sDCR-1FL DCR-1
Helicase     DUF     PAZ                   RIIIa    RIIIb RBD     
FL DCR-1
ALG 1/2
Figure 5. sDCR-1 Tilts the Balance of RNAi
Pathways
Full-length DCR-1 is proteolytically cleaved to
produce sDCR-1, a C-terminal fragment contain-
ing the catalytic domains and lacking many regu-
latory domains: helicase, DUF, and PAZ. sDCR-1
enhances exoRNAi, possibly through inherent
higher catalytic activity due to the loss of the
autoinhibitory helicase domain, and inhibits the
miRNA maturation pathway by sequestering
miRNA-dedicated Argonautes, causing an accu-
mulation of precursor miRNA and reduction of
mature miRNA levels.of short Dicer forms bears important implications, as Dicer acts
as a tumor suppressor in specific cancers (Grelier et al., 2009;
Karube et al., 2005; Valastyan and Weinberg, 2010). Ultimately,
the impact of aberrant DICER expression in cancer should
depend on the specific gene lesions, the balance of the iso-
forms represented, and the precise portfolio of the miRNAs
expressed.
EXPERIMENTAL PROCEDURES
C. elegans Strains and RNAi Assays
All strains were cultured as in Brenner (1974). N2 was used as the wild-type
strain. Alleles used were glp-4(bn2) and fem-1(hc17). RNAi was performed
as in Fire et al. (1998) and Timmons et al. (2001) on L4 stage P0 animals and
harvested/scored at gravid adult F1 animals. A description of the transgenic
strains is provided in the Extended Experimental Procedures. DCR-1 (m+/
z) samples were obtained as in Duchaine et al. (2006). The let-7 tempera-
ture-sensitive allele (n2853) and the ALG-2::GFP transgenic rescue strain
(MJS26)(Vasquez-Rifo et al., 2012) were kind gifts from Dr. Martin Simard.
Sample Preparation
Pellets were homogenized in 50 mM Tris-HCl pH 8/150 mM NaCl/1 mM EDTA
with Complete EDTA-free protease inhibitors (Roche) and cleared by 10,0003
g (S10) or 100,000 3 g (S100) centrifugation. For IP, extracts were supple-
mented to 1% Triton X-100 prior to antibody incubation. For IP-northern blot
experiments, the lysis buffer used was 30 mM 2-[4-(2-hydroxyethyl)pipera-
zine-1-yl]ethanesulfonic acid (HEPES)-KOH pH 7.4/150 mM KOAc/5 mM
Mg(OAc)2/0.1% Igepal with RiboLock RNase inhibitor (Thermo Scientific),
and RNA was isolated from S10 extracts, unbound samples, and IPs with
phenol/chloroform extraction. See the Extended Experimental Procedures
for antibodies used.Northern Blotting
Northern blotting was performed as in Thivierge et al. (2012). Data were quan-
tified using Image J. Statistical significance was calculated using independent
two-tailed Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and two tables and can be found with this article online at http://dx.
doi.org/10.1016/j.celrep.2013.07.013.
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